Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco Dorsey Wright Momentum ETF
PDP
|
+$591M |
| 2 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$240M |
| 3 |
Boston Scientific
BSX
|
+$194M |
| 4 |
SCHW
Charles Schwab
SCHW
|
+$193M |
| 5 |
Clarivate
CLVT
|
+$158M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.25B |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$809M |
| 3 |
Willis Towers Watson
WTW
|
+$664M |
| 4 |
AstraZeneca
AZN
|
+$658M |
| 5 |
Microsoft
MSFT
|
+$573M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.19% |
| 2 | Financials | 6.48% |
| 3 | Consumer Discretionary | 5.4% |
| 4 | Healthcare | 5.05% |
| 5 | Communication Services | 4.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3101
Texas Roadhouse
TXRH
$13.5B
| $938K | ﹤0.01% |
10,273
+5,012
| +95% | +$468K |
|
3102
Talos Energy
TALO
$2.53B
| $935K | ﹤0.01% |
67,912
+2,866
| +4% | +$34.9K |
|
|
MAAC
3103
DELISTED
Montes Archimedes Acquisition Corp. Class A Common Stock
MAAC
| $935K | ﹤0.01% |
100,000
-79,262
| -44% | -$787K |
|
|
JYAC
3104
DELISTED
Jiya Acquisition Corp. Class A Common Stock
JYAC
| $932K | ﹤0.01% |
95,343
| – | – |
|
3105
Knowles
KN
$3.13B
| $929K | ﹤0.01% |
49,579
-9,542
| -16% | -$187K |
|
3106
G-III Apparel Group
GIII
$1.54B
| $928K | ﹤0.01% |
32,804
-12,277
| -27% | -$370K |
|
|
SGI
3107
CALL
Somnigroup International
SGI
$13.7B
| $928K | ﹤0.01% |
+20,000
| New | +$874K |
|
|
ATIP
3108
DELISTED
ATI Physical Therapy, Inc.
ATIP
| $927K | ﹤0.01% |
+4,878
| New | +$1.24M |
|
3109
Mercury Insurance
MCY
$5.93B
| $926K | ﹤0.01% |
16,647
-3,558
| -18% | -$212K |
|
3110
US Physical Therapy
USPH
$1.2B
| $926K | ﹤0.01% |
8,365
-1,292
| -13% | -$147K |
|
3111
PUT
Trip.com Group
TCOM
$29.6B
| $923K | ﹤0.01% |
30,000
| – | – |
|
3112
Copa Holdings
CPA
$5.76B
| $918K | ﹤0.01% |
11,272
-8,450
| -43% | -$632K |
|
3113
AZZ Inc
AZZ
$4.35B
| $915K | ﹤0.01% |
17,208
-4,964
| -22% | -$261K |
|
3114
CTS Corp
CTS
$1.83B
| $913K | ﹤0.01% |
29,543
-4,760
| -14% | -$163K |
|
3115
Verastem
VSTM
$510M
| $913K | ﹤0.01% |
24,695
-6,813
| -22% | -$250K |
|
3116
OSI Systems
OSIS
$3.65B
| $907K | ﹤0.01% |
9,570
-59
| -0.6% | -$5.75K |
|
3117
Protagonist Therapeutics
PTGX
$8.79B
| $907K | ﹤0.01% |
51,185
-21,355
| -29% | -$910K |
|
3118
Green Brick Partners
GRBK
$3.04B
| $906K | ﹤0.01% |
44,163
-6,921
| -14% | -$163K |
|
|
YMAB
3119
DELISTED
Y-mAbs Therapeutics
YMAB
| $906K | ﹤0.01% |
31,756
-41,546
| -57% | -$1.31M |
|
|
BBT
3120
Beacon Financial Corp
BBT
$2.66B
| $905K | ﹤0.01% |
33,544
-26,260
| -44% | -$694K |
|
|
VRTV
3121
DELISTED
VERITIV CORPORATION
VRTV
| $904K | ﹤0.01% |
10,092
+2,881
| +40% | +$220K |
|
|
FMTX
3122
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
| $903K | ﹤0.01% |
38,953
-108,577
| -74% | -$2.57M |
|
3123
Northwest Bancshares
NWBI
$2.3B
| $901K | ﹤0.01% |
67,887
-6,021
| -8% | -$79.1K |
|
|
JWN
3124
PUT
DELISTED
Nordstrom
JWN
| $899K | ﹤0.01% |
34,000
| – | – |
|
3125
Global X SuperDividend REIT ETF
SRET
$233M
| $899K | ﹤0.01% |
31,500
+4,588
| +17% | +$134K |
|
Similar funds
Citigroup's Q3 2021 Portfolio in Review
As of Q3 2021, Citigroup held 6,611 positions worth $169B, up 1.9% from $166B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Citigroup deployed $5.8B of net new capital in Q3 2021, opening 423 new positions and adding to 2,034 existing holdings. Its largest new stake was Hennessy Capital Investment Corp. VI Unit: 9,095,000 shares worth $90.5M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 12% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $2.25B trimmed.
- Citigroup's largest Q3 2021 buy was Hennessy Capital Investment Corp. VI Unit: 9,095,000 shares worth $90.5M.
- Citigroup added most to Invesco Dorsey Wright Momentum ETF in Q3 2021, an estimated $591M increase.
- Citigroup's biggest Q3 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.25B.
- Citigroup fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $809M.
- Citigroup's ten largest holdings make up 25% of its $169B portfolio in Q3 2021.
- Citigroup opened 423 new positions and closed 793 in Q3 2021.
- Citigroup's portfolio value rose 1.9% quarter-over-quarter to $169B.
Based on Citigroup's 13F filing for Q3 2021, filed 10 Nov 2021.